{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:57:36Z","timestamp":1755226656243,"version":"3.43.0"},"reference-count":32,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Traditional pain management pathways following craniotomy are predicated on opioids. However, narcotics can confound critical neurological examination, contribute to respiratory depression, lower the seizure threshold, and lead to medication habituation, dependence, and\/or abuse. Alternative medications to better address postoperative pain while mitigating opioid-related adverse effects remain insufficiently studied. Preliminary studies suggest sumatriptan, a 5-HT (1B\/1D) receptor agonist known to regulate dural vasoactivity and inflammation, may moderate pain following trigeminal microvascular decompression and chronic postcraniotomy headache. In this study, the authors evaluated the efficacy of sumatriptan to modulate pain and opioid requirements following craniotomy surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>This was a single academic center, retrospective cohort study of 300 consecutive adult patients who underwent elective craniotomy surgery between 2015 and 2022. Patients were equally divided between a control and a sumatriptan cohort contingent upon administration of 6 mg of subcutaneous sumatriptan within 1 hour of surgery completion and prior to opioid administration. Postoperative opioid consumption at 6, 12, and 24 hours, as well as admission total, inpatient length of stay, and 30-day global reevaluation, were assessed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Three hundred patients were included for analysis. Significant differences were seen in baseline hypertension (p &lt; 0.01), hyperlipemia (p &lt; 0.01), anxiety (p = 0.04), and operative time (p = 0.02). A significant reduction of mean postoperative pain scores at 12 (p = 0.03) and 24 (p &lt; 0.01) hours and total opioid consumption (p = 0.04) was observed in the sumatriptan cohort. Subgroup analysis revealed significantly lower postoperative pain scores at 6 (p = 0.05), 12 (p &lt; 0.01), and 24 (p &lt; 0.01) hours in patients who underwent burr hole placement in the sumatriptan cohort as compared with controls; however, no significant difference in opioid consumption was noted. No adverse events related to sumatriptan administration were noted throughout the study.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Postoperative single-dose subcutaneous sumatriptan following elective craniotomy may reduce pain scores and opioid requirements. Additional studies are needed to better understand nuanced differences in opioid modulation and optimal patient selection.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.5.jns232827","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T01:29:28Z","timestamp":1724462968000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of subcutaneous sumatriptan in postcraniotomy pain and opioid consumption"],"prefix":"10.3171","author":[{"given":"Josha","family":"Woodward","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Herbst","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashka","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Meza","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacin","family":"Koro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Kolb","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Panos","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan A.","family":"Munich","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo F.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepehr","family":"Sani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Surg Neurol Int","first-page":"291","article-title":"Designing a pain management protocol for craniotomy: a narrative review and consideration of promising practices","volume":"8","author":"Vacas S","year":"2017","unstructured":"Vacas S, Van de Wiele B. Designing a pain management protocol for craniotomy: a narrative review and consideration of promising practices. Surg Neurol Int. 2017;8:291."},{"issue":"3","key":"b2","series-title":"J Neurosurg Anesthesiol","first-page":"231","article-title":"Scheduled intravenous acetaminophen improves patient satisfaction with postcraniotomy pain management: a prospective, randomized, placebo-controlled, double-blind study","volume":"30","author":"Artime CA","year":"2018","unstructured":"Artime CA, Aijazi H, Zhang H,  Scheduled intravenous acetaminophen improves patient satisfaction with postcraniotomy pain management: a prospective, randomized, placebo-controlled, double-blind study. J Neurosurg Anesthesiol. 2018;30(3):231\u2013236."},{"issue":"7","key":"b3","series-title":"JAMA Intern Med","first-page":"958","article-title":"Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis","volume":"176","author":"Abdel Shaheed C","year":"2016","unstructured":"Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958\u2013968."},{"issue":"4","key":"b4","series-title":"Ann Intern Med","first-page":"276","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou R","year":"2015","unstructured":"Chou R, Turner JA, Devine EB,  The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276\u2013286."},{"issue":"9","key":"b5","series-title":"JAMA","first-page":"872","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE Randomized Clinical Trial","volume":"319","author":"Krebs EE","year":"2018","unstructured":"Krebs EE, Gravely A, Nugent S,  Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE Randomized Clinical Trial. JAMA. 2018;319(9):872\u2013882."},{"key":"b6","series-title":"Neuropharmacology","first-page":"160","article-title":"Serotonergic mechanisms of trigeminal meningeal nociception: implications for migraine pain","volume":"116","author":"Kilinc E","year":"2017","unstructured":"Kilinc E, Guerrero-Toro C, Zakharov A,  Serotonergic mechanisms of trigeminal meningeal nociception: implications for migraine pain. Neuropharmacology. 2017;116:160\u2013173."},{"issue":"1","key":"b7","series-title":"Br J Anaesth","first-page":"73","article-title":"Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression","volume":"117","author":"Venkatraghavan L","year":"2016","unstructured":"Venkatraghavan L, Li L, Bailey T, Manninen PH, Tymianski M. Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression. Br J Anaesth. 2016;117(1):73\u201379."},{"issue":"2","key":"b8","series-title":"J Neurosurg","first-page":"401","article-title":"Subcutaneous sumatriptan: association with decreases in postoperative pain and opioid use after elective cranial surgery","volume":"134","author":"Patel KS","year":"2020","unstructured":"Patel KS, Laiwalla AN, DiCesare JAT, Garrett MC, Wang AC. Subcutaneous sumatriptan: association with decreases in postoperative pain and opioid use after elective cranial surgery. J Neurosurg. 2020;134(2):401\u2013409."},{"issue":"8","key":"b9","series-title":"BMJ Open","first-page":"e032388","article-title":"Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial","volume":"9","author":"Licina A","year":"2019","unstructured":"Licina A, Russell J, Silvers A, Jin X, Denny J. Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial. BMJ Open. 2019;9(8):e032388."},{"issue":"3","key":"b10","series-title":"Pain Rep","first-page":"e948","article-title":"Efficacy of an opioid-sparing analgesic protocol in pain control after less invasive cranial neurosurgery","volume":"6","author":"Ahmad S","year":"2021","unstructured":"Ahmad S, Khanna R, Onyewuenyi AC, Panos N, Breslin R, Sani S. Efficacy of an opioid-sparing analgesic protocol in pain control after less invasive cranial neurosurgery. Pain Rep. 2021;6(3):e948."},{"key":"b11","series-title":"Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors table for prescription drug coverage","article-title":"Centers for Medicare & Medicaid Services, US Department of Health and Human Services","year":"2020","unstructured":"Centers for Medicare & Medicaid Services, US Department of Health and Human Services. Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors table for prescription drug coverage. US Department of Health and Human Services Guidance Portal; 2020.Accessed June 6, 2024. https:\/\/www.hhs.gov\/guidance\/document\/opioid-oral-morphine-milligram-equivalent-mme-conversion-factors-0"},{"issue":"15","key":"b12","series-title":"JAMA","first-page":"1654","article-title":"Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012","volume":"315","author":"Wunsch H","year":"2016","unstructured":"Wunsch H, Wijeysundera DN, Passarella MA, Neuman MD. Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012. JAMA. 2016;315(15):1654\u20131657."},{"issue":"5","key":"b13","series-title":"Anesth Analg","first-page":"1733","article-title":"Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic","volume":"125","author":"Hah JM","year":"2017","unstructured":"Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg. 2017;125(5):1733\u20131740."},{"issue":"5","key":"b14","series-title":"J Gen Intern Med","first-page":"478","article-title":"Opioid prescribing at hospital discharge contributes to chronic opioid use","volume":"31","author":"Calcaterra SL","year":"2016","unstructured":"Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med. 2016;31(5):478\u2013485."},{"issue":"Suppl","key":"b15","series-title":"Clin Neurol Neurosurg","first-page":"S73","article-title":"Clinical effects and mechanism of action of sumatriptan in migraine","volume":"94","author":"Ferrari MD","year":"1992","unstructured":"Ferrari MD, Saxena PR. Clinical effects and mechanism of action of sumatriptan in migraine. Clin Neurol Neurosurg. 1992;94(Suppl):S73\u2013S77."},{"issue":"5","key":"b16","series-title":"Arch Neurol","first-page":"712","article-title":"Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin","volume":"55","author":"Meschia JF","year":"1998","unstructured":"Meschia JF, Malkoff MD, Biller J. Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin. Arch Neurol. 1998;55(5):712\u2013714."},{"issue":"23","key":"b17","series-title":"Intern Med","first-page":"3525","article-title":"Triptan-induced reversible cerebral vasoconstriction syndrome: two case reports with a literature review","volume":"55","author":"Kato Y","year":"2016","unstructured":"Kato Y, Hayashi T, Mizuno S,  Triptan-induced reversible cerebral vasoconstriction syndrome: two case reports with a literature review. Intern Med. 2016;55(23):3525\u20133528."},{"issue":"5","key":"b18","series-title":"Intensive Care Med","first-page":"532","article-title":"Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine\u2014a case report","volume":"25","author":"Granier I","year":"1999","unstructured":"Granier I, Garcia E, Geissler A, Boespflug MD, Durand-Gasselin J. Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine\u2014a case report. Intensive Care Med. 1999;25(5):532\u2013534."},{"issue":"9","key":"b19","series-title":"Neurology","first-page":"1243","article-title":"Intracranial hemorrhages associated with sumatriptan","volume":"56","author":"Combremont PC","year":"2001","unstructured":"Combremont PC, Marcus EM. Intracranial hemorrhages associated with sumatriptan. Neurology. 2001;56(9):1243\u20131244."},{"key":"b20","series-title":"Front Med (Lausanne)","first-page":"23","article-title":"Perioperative factors contributing the post-craniotomy pain: a synthesis of concepts","volume":"4","author":"Chowdhury T","year":"2017","unstructured":"Chowdhury T, Garg R, Sheshadri V,  Perioperative factors contributing the post-craniotomy pain: a synthesis of concepts. Front Med (Lausanne). 2017;4:23."},{"issue":"2","key":"b21","series-title":"J Neurosurg","first-page":"210","article-title":"Prospective evaluation of pain and analgesic use following major elective intracranial surgery","volume":"106","author":"Gottschalk A","year":"2007","unstructured":"Gottschalk A, Berkow LC, Stevens RD,  Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg. 2007;106(2):210\u2013216."},{"issue":"7","key":"b22","series-title":"Can J Anaesth","first-page":"544","article-title":"Craniotomy site influences postoperative pain following neurosurgical procedures: a retrospective study","volume":"54","author":"Thibault M","year":"2007","unstructured":"Thibault M, Girard F, Moumdjian R, Chouinard P, Boudreault D, Ruel M. Craniotomy site influences postoperative pain following neurosurgical procedures: a retrospective study. Can J Anaesth. 2007;54(7):544\u2013548."},{"issue":"4","key":"b23","series-title":"J Anesth","first-page":"227","article-title":"The effect of craniotomy location on postoperative pain and nausea","volume":"17","author":"Irefin SA","year":"2003","unstructured":"Irefin SA, Schubert A, Bloomfield EL, DeBoer GE, Mascha EJ, Ebrahim ZY. The effect of craniotomy location on postoperative pain and nausea. J Anesth. 2003;17(4):227\u2013231."},{"issue":"1","key":"b24","series-title":"Sci Rep","first-page":"9755","article-title":"Ambulatory surgery protocol for endoscopic endonasal resection of pituitary adenomas: a prospective single-arm trial with initial implementation experience","volume":"10","author":"Liu Y","year":"2020","unstructured":"Liu Y, Zheng T, Lv W,  Ambulatory surgery protocol for endoscopic endonasal resection of pituitary adenomas: a prospective single-arm trial with initial implementation experience. Sci Rep. 2020;10(1):9755."},{"issue":"4","key":"b25","series-title":"J Neurol Surg B Skull Base","first-page":"397","article-title":"Postoperative pain management and perceived patient outcomes following endoscopic pituitary surgery","volume":"83","author":"Hoke ATK","year":"2021","unstructured":"Hoke ATK, Malfitano M, Zanation AM,  Postoperative pain management and perceived patient outcomes following endoscopic pituitary surgery. J Neurol Surg B Skull Base. 2021;83(4):397\u2013404."},{"issue":"3","key":"b26","series-title":"Am J Rhinol Allergy","first-page":"339","article-title":"Opiate use after endoscopic endonasal transsphenoidal surgery","volume":"36","author":"Wu TJ","year":"2022","unstructured":"Wu TJ, Kianian R, Villalpando EG,  Opiate use after endoscopic endonasal transsphenoidal surgery. Am J Rhinol Allergy. 2022;36(3):339\u2013347."},{"issue":"2","key":"b27","series-title":"Pain Physician","first-page":"357","article-title":"Drug-related side effects of long-term intrathecal morphine therapy","volume":"10","author":"Ruan X","year":"2007","unstructured":"Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10(2):357\u2013366."},{"issue":"5","key":"b28","series-title":"Drug Saf","first-page":"373","article-title":"Drug-induced urinary retention: incidence, management and prevention","volume":"31","author":"Verhamme KMC","year":"2008","unstructured":"Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373\u2013388."},{"issue":"4","key":"b29","series-title":"Best Pract Res Clin Anaesthesiol","first-page":"499","article-title":"Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature","volume":"31","author":"de Boer HD","year":"2017","unstructured":"de Boer HD, Detriche O, Forget P. Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol. 2017;31(4):499\u2013504."},{"issue":"5","key":"b30","series-title":"Anesthesiology","first-page":"1139","article-title":"Postoperative urinary retention: anesthetic and perioperative considerations","volume":"110","author":"Baldini G","year":"2009","unstructured":"Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009;110(5):1139\u20131157."},{"issue":"3","key":"b31","series-title":"Curr Opin Anaesthesiol","first-page":"361","article-title":"Maintaining micturition in the perioperative period: strategies to avoid urinary retention","volume":"26","author":"Choi S","year":"2013","unstructured":"Choi S, Awad I. Maintaining micturition in the perioperative period: strategies to avoid urinary retention. Curr Opin Anaesthesiol. 2013;26(3):361\u2013367."},{"key":"b32","series-title":"Surg Neurol Int","first-page":"61","article-title":"The incidence and risk factors for postoperative urinary retention in neurosurgical patients","volume":"4","author":"Alsaidi M","year":"2013","unstructured":"Alsaidi M, Guanio J, Basheer A,  The incidence and risk factors for postoperative urinary retention in neurosurgical patients. Surg Neurol Int. 2013;4:61."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.5.JNS232827\/article-10.3171-2024.5.JNS232827.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.5.JNS232827\/article-10.3171-2024.5.JNS232827.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.5.JNS232827\/article-10.3171-2024.5.JNS232827.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T01:19:10Z","timestamp":1738372750000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.5.JNS232827\/article-10.3171-2024.5.JNS232827.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3171\/2024.5.jns232827","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"type":"print","value":"0022-3085"},{"type":"electronic","value":"1933-0693"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}